Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2016 Financial Results on May 9, 2016 4/25/16 CMS Determines that Existing J-Code J9033 Adequately Describes BENDEKA (bendamustine hydrochloride) Injection 4/20/16 Eagle Pharmaceuticals and the National Institutes of Health (NIH/NIDA) Enter into Agreement to Explore Use of Ryanodex in MDMA (Ecstasy) and Methamphetamine Intoxication 3/28/16 Eagle Pharmaceuticals Receives Complete Response Letter from FDA on KANGIO (RTU bivalirudin) Application 3/18/16 FDA Does Not Grant Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection) 3/8/16 Eagle Pharmaceuticals Receives Sixth Patent for Bendamustine 2/23/16 Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2015 Results 2/15/16 Eagle Pharmaceuticals to Present at RBC Capital Markets 2016 Global Healthcare Conference 2/10/16 Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2015 Financial Results on February 25, 2016 2/5/16 Eagle Pharmaceuticals Announces Appointment of Michael Moran as U.S. Head of Sales 2/4/16 Pagination First page Previous page Page 1 Page 2 Current page 3 Page 4 Next page Last page
